ClinicalTrials.gov
ClinicalTrials.gov Menu

Blue Light Intraocular Lenses (IOLs) and Photostress

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00710996
Recruitment Status : Completed
First Posted : July 8, 2008
Results First Posted : January 29, 2010
Last Update Posted : February 2, 2010
Sponsor:
Information provided by:
Alcon Research

Brief Summary:
To determine what effect a blue light filtering Intraocular Lens (IOL) has on macular pigment levels.

Condition or disease
Cataract

Study Type : Observational
Actual Enrollment : 58 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Blue Light Intraocular Lenses (IOLs) and Photostress
Study Start Date : January 2008
Actual Primary Completion Date : October 2008
Actual Study Completion Date : October 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract

Group/Cohort
AcrySof Natural Intraocular Lens
AcrySof Natural Intraocular Lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SN"
AcrySof clear intraocular lens
AcrySof clear intraocular lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SA"
Phakic patients
Phakic patients - Age matched patients who have not had cataract surgery



Primary Outcome Measures :
  1. Photostress Recovery Time in Seconds. [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with existing bilateral Intraocular Lenses (IOLs) of given type, age-matched patients with normal vision and no cataract surgery.
Criteria

Inclusion Criteria:

  • Patients with existing bilateral IOLs of given type, age-matched patients with normal vision and no cataract surgery.

Exclusion Criteria:

  • Age related

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00710996


Locations
United States, Texas
Call Alcon Call Center for Study Locations
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Rick Potvin, Alcon Laboratories, Inc.
ClinicalTrials.gov Identifier: NCT00710996     History of Changes
Other Study ID Numbers: M07-023
First Posted: July 8, 2008    Key Record Dates
Results First Posted: January 29, 2010
Last Update Posted: February 2, 2010
Last Verified: January 2010

Keywords provided by Alcon Research:
AcrySof IQ IOL

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases